• UCLA Health
  • myUCLAhealth
  • School of Medicine
U Magazine

U Magazine

U Magazine
  • Home
  • Current Issue
  • Centennial Campaign for UCLA Issue
  • Browse U Magazine
  • Letters to the Editor
  • Subscribe
  • Contact
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

U Magazine

Browse U Magazine

  1. Home
  2. Browse U Magazine
Share this
The Cutting Edge

Blood Test Serves as Crystal Ball for Heart-transplant Patients

A blood test commonly used to determine whether or not heart-transplant recipients are rejecting their new organ can also predict potential rejectionrelated problems in the future, a UCLA-led study finds. The researchers demonstrated how the AlloMap test, which uses a blood sample to measure changes in the expression of roughly a dozen genes, can be used over a period of time to assess the risk of dysfunction or rejection of a transplanted heart — months before such an event may occur.

  Blood Test
  Photo: Superstock Images

“For the first time, we can use genomic testing over multiple patient visits to go beyond intuition to understand not just how patients are doing now, but also how they are likely to be a few months from now,” says Mario Deng, MD, medical director of UCLA’s Integrated Advanced Heart Failure-Mechanical Support-Heart Transplant Program. “It’s another step toward personalized medicine.”

The discovery that the white blood cells of transplant recipients contain this prognostic information on rejection, independent of how their transplanted heart may be functioning, could potentially improve care and outcomes, the researchers said.

AlloMap, which is based on research led by Dr. Deng in conjunction with more than a dozen of the largest U.S. heart-transplant centers and the Brisbane, California-based biotech company XDx, measures the expression levels of 11 genes from a patient’s blood sample, each of which is known to be associated with rejection risk. The current study is based on data originally collected by leading transplant centers and published in the New England Journal of Medicine in 2010. For that study, 600 heart-transplant recipients were randomly assigned to be monitored for potential episodes of rejection either through routine biopsy or through the AlloMap test. The study found that AlloMap was equally as effective as biopsy at detecting rejection or dysfunction, and it resulted in increased patient satisfaction because it was less invasive. The new study demonstrates for the first time the ability of the AlloMap test, when used over time, to predict future events.

Dr. Deng and colleagues noted that using gene-expression profiling to predict the future likelihood of patients experiencing rejection-related problems with their transplanted heart could change the way such patients are treated. For example, those deemed to be at low risk for adverse events could be given lower doses of immunosuppressive drugs, which could reduce the significant side effects. Or patients found to be at high risk could be evaluated at shorter time intervals to determine the causes of the test-result variability, specifically to rule out rejection.

 “Utility of Gene Expression Profiling Score Variability to Predict Clinical Events in Heart Transplant Recipients,” Transplantation, January 31, 2014


Previous
Older Adults: Build Muscle to Live Longer
Next
Increased Pesticide Links to Parkinson’s Disease


YOU ARE VIEWING

Summer 2014

Summer 2014
E-Brochure
Printable PDF
IN THIS ISSUE
  • Fully Engaged
  • Picturing Pain
  • UV Light Aids Creeping Cancer Cells
  • Older Adults: Build Muscle to Live Longer
  • Blood Test Serves as Crystal Ball for Heart-transplant Patients
  • Increased Pesticide Links to Parkinson’s Disease
  • Vitamin A vs. Tuberculosis
  • Understanding the Genetics of Bipolar Disorder
  • Hints Gleaned from Cold Virus Point to Potential Cancer Treatments
  • Heart-Lung Machine Saves Heart-attack Victim
  • Acetaminophen Use during Pregnancy Linked to ADHD
  • On-ramp to the Fast Track
  • Partners in Care
  • Body Language
  • Game Changer
  • The Guardians
  • Awards/Honors
  • Going Global
  • In Her Own Words: Hollanda Leon, MD ’99
  • Postcard from Guatemala
  • A Sampling of French Favorites Benefits UCLA’s Jonsson Comprehensive Cancer Center
  • People-Animal Connection Friends Spread Love for Valentine’s Day
  • L.A. Fun Ride Promotes UCLA Blood and Platelet Center
  • Through the Looking Glass Brightly
  • Construction of Connie Frank Kidney Transplant Center Begins
  • In Memoriam
  • Gifts
  • Extending a Helping Hand for Healthcare
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth